MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0146960
RN Ppe Products Private Limited
RN Ppe Products Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.8 Lakh
▼ 94% YoY
Net loss · FY 2025
₹8.47 Lakh
Net margin -57.2%
EBITDA · FY 2025
-₹8.47 Lakh
EBITDA margin -57.2%
Authorised capital
₹20,000
Registered with MCA
Paid-up capital
₹20,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About RN Ppe Products Private Limited
Data last updated:
RN Ppe Products Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC340940. Its GSTIN is 27AAKCR2247P1ZR (Maharashtra).
The company has an authorised share capital of ₹20,000 and a paid-up capital of ₹20,000. It is led by directors Naresh Kulbhushan Kapur and Mamta Kapur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 236 Veena Mall Sweetland Layout Opp W.E.Highway Kandivali East, Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.8 Lakh, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹8.47 Lakh (net margin -57.2%) and EBITDA of -₹8.47 Lakh (EBITDA margin -57.2%). Revenue has declined at a compounded annual rate (CAGR) of 48% over three years.
RN Ppe Products Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0146960).
Company details
CIN U74999MH2020PTC340940
Registration Number 340940
Incorporation Date 23 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0146960
Recognitions & Rankings of RN Ppe Products
Contact details
RN Ppe Products Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 236 Veena Mall Sweetland Layout Opp W.E.Highway Kandivali East, Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of RN Ppe Products Private Limited, buy the company report.
Comprehensive company report
RN Ppe Products Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of RN Ppe Products is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of RN Ppe Products Private Limited, buy the company report.
Financials of RN Ppe Products Private Limited
FY 2025 filings availableRN Ppe Products Private Limited reported revenue of ₹14.8 Lakh (down 94% YoY) for FY 2025.
Revenue · FY 2025
₹14.8 Lakh ▼ 94%
Net loss · FY 2025
₹8.47 Lakh margin -57.2%
EBITDA · FY 2025
-₹8.47 Lakh margin -57.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 94%
3 years · compounded
▼ 48%
EBITDA CAGR growth
3 years · compounded
▼ 60%
Revenue has declined at a compounded annual rate (CAGR) of 48% over three years, including a 94% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -57.2% | ||||
| Net Profit Margin | -57.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of RN Ppe Products Private Limited, buy the company report.
Board of directors of RN Ppe Products Private Limited
RN Ppe Products has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Kulbhushan Kapur | Director | 23 Jun 2020 | 6 Years 4 Months | Current |
| Mamta Kapur Also directs: HTD Digital Private Limited | Director | 23 Jun 2020 | 6 Years 4 Months | Current |
Auditor
RN Ppe Products Private Limited is audited by R R GANDHI AND CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R R GANDHI AND CO | FY 2022 | 145617W |
Shareholding
The shareholding of RN Ppe Products Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of RN Ppe Products Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving RN Ppe Products Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RN Ppe Products Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
RN Ppe Products Private Limited has 1 active EPFO establishment as of Mar 21, 2024.
Active EPFO establishments
1
GST
RN Ppe Products has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCR2247P1ZR | Maharashtra | Active | 25 Jun 2020 |
To see the full GST registrations and return filing status of RN Ppe Products Private Limited, buy the company report.
Recent activity
RN Ppe Products Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Mamta Kapur was appointed as Director on 23 Jun 2020.
AGM
Rn Ppe Products Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rn Ppe Products Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Mamta Kapur was appointed as Director.
Appointed
Naresh Kulbhushan Kapur was appointed as Director.
Incorporation
23 Jun 2020
Rn Ppe Products Private Limited was registered on 23 Jun 2020 with Roc Mumbai I & aged 6 years 4 months as per MCA records.
Frequently asked questions
RN Ppe Products is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 June 2020 (6+ years old) and is registered under CIN U74999MH2020PTC340940.
RN Ppe Products has 2 current directors:
- Naresh Kulbhushan Kapur - Director
- Mamta Kapur - Director
The latest financial statements of RN Ppe Products on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of RN Ppe Products is 27AAKCR2247P1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of RN Ppe Products is U74999MH2020PTC340940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RN Ppe Products was incorporated on 23 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Mamta Kapur was appointed as Director on 23 Jun 2020. Naresh Kulbhushan Kapur was appointed as Director on 23 Jun 2020.
Yes, RN Ppe Products is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0146960).
The registered office of RN Ppe Products is at Shop No 236 Veena Mall Sweetland Layout Opp W.E.Highway Kandivali East, Mumbai, Maharashtra, India – 400101.
RN Ppe Products operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages